Diclofenac 50mg + Paracetamol 500mg Tablet Franchise in Ahmedabad

Decplist Plus Tablet Distributor in Hyderabad

Decplist Plus Tablet Distributor in Hyderabad

Musculoskeletal Pain & Analgesic Franchise Opportunity in Jaipur

Anti-inflammatory & Pain Relief Tablet Stockist in Mumbai
Diclofenac-Paracetamol Combination Export & Manufacturing in Chandigarh

Home/Products /diclofenac-50mg-paracetamol-500mg-tablet

Decplist Plus Tablet

Composition : Diclofenac (50mg) + Paracetamol (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Decplist Plus Tablet contains Diclofenac 50mg + Paracetamol 500mg, a synergistic combination designed for fast and effective relief from pain, inflammation, and fever. This dual-action formula is widely used for musculoskeletal pain, arthritis, post-injury discomfort, and general analgesic needs, providing both anti-inflammatory and antipyretic effects.

Diclofenac acts as a potent NSAID, reducing pain and inflammation, while Paracetamol complements it by alleviating fever and enhancing analgesic efficacy. Together, they deliver comprehensive relief for patients experiencing acute or chronic pain episodes, improving mobility and comfort.

For hospitals, clinics, and distributors, Decplist Plus Tablet is a high-demand combination therapy, widely prescribed in orthopedic, general medicine, and physiotherapy settings. Its dual action ensures a broader prescription base and consistent market movement across retail pharmacies, hospitals, and multispecialty healthcare centers.

Including Decplist Plus Tablet in your product portfolio strengthens your pain management and analgesic therapy segment, offering strong opportunities in hospital supply, institutional orders, export channels, and third-party manufacturing. Its clinically proven efficacy and high prescription rate make it a valuable addition for pharmaceutical distributors.

Read More

About the Product

Decplist Plus Tablet contains Diclofenac 50mg + Paracetamol 500mg, a synergistic combination designed for fast and effective relief from pain, inflammation, and fever. This dual-action formula is widely used for musculoskeletal pain, arthritis, post-injury discomfort, and general analgesic needs, providing both anti-inflammatory and antipyretic effects.

Diclofenac acts as a potent NSAID, reducing pain and inflammation, while Paracetamol complements it by alleviating fever and enhancing analgesic efficacy. Together, they deliver comprehensive relief for patients experiencing acute or chronic pain episodes, improving mobility and comfort.

For hospitals, clinics, and distributors, Decplist Plus Tablet is a high-demand combination therapy, widely prescribed in orthopedic, general medicine, and physiotherapy settings. Its dual action ensures a broader prescription base and consistent market movement across retail pharmacies, hospitals, and multispecialty healthcare centers.

Including Decplist Plus Tablet in your product portfolio strengthens your pain management and analgesic therapy segment, offering strong opportunities in hospital supply, institutional orders, export channels, and third-party manufacturing. Its clinically proven efficacy and high prescription rate make it a valuable addition for pharmaceutical distributors.

Some patients may experience nausea, vomiting, stomach discomfort, or mild headache. Rarely, allergic reactions, liver dysfunction (from Paracetamol), or gastrointestinal bleeding (from Diclofenac) may occur.

It is indicated for the treatment of acute pain, musculoskeletal pain, arthritis, postoperative pain, and fever. The combination helps relieve pain faster and more effectively than either agent alone, improving patient comfort and mobility.

Use only under medical supervision. Avoid in patients with hypersensitivity to Diclofenac, Paracetamol, history of peptic ulcer, or severe liver/kidney impairment. Follow the prescribed dose and avoid prolonged use without consulting a healthcare professional.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.